Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 Jun 21:9:84.
doi: 10.1186/1477-7827-9-84.

Extended letrozole regimen versus clomiphene citrate for superovulation in patients with unexplained infertility undergoing intrauterine insemination: a randomized controlled trial

Usama M Fouda  1 , Ahmed M Sayed
Affiliations
Randomized Controlled Trial

Extended letrozole regimen versus clomiphene citrate for superovulation in patients with unexplained infertility undergoing intrauterine insemination: a randomized controlled trial

Usama M Fouda et al. Reprod Biol Endocrinol. .

Abstract

Background: The aim of this randomized controlled trial was to compare the efficacy of extended letrozole regimen with clomiphene citrate in women with unexplained infertility undergoing superovulation and intrauterine insemination (IUI).

Methods: Two hundred and fourteen patients with unexplained infertility were randomized into two equal groups using computer generated list and were treated by either letrozole 2.5 mg/day from cycle day 1 to 9 (extended letrozole group, 211 cycles) or clomiphene citrate 100 mg/day from cycle day 3 to 7 (clomiphene citrate group,210 cycles). Intrauterine insemination was performed 36 to 40 hours after HCG administration.

Results: Both groups were comparable with regard to number of mature follicles (2.24 +/- 0.80 Vs 2.13 +/- 0.76) and the day of HCG administration. Serum estradiol was significantly greater in clomiphene citrate group (356 +/- 151 Vs 822 +/- 302 pg/ml, P = < 0.001) and the endometrial thickness was significantly greater in extended letrozole group (9.10 +/- 1.84 Vs 8.18 +/- 1.93 mm, P = < 0.001).The pregnancy rate per cycle and cumulative pregnancy rate were significantly greater in extended letrozole group (18.96% Vs 11.43% and 37.73% Vs 22.86%, respectively).

Conclusion: The extended letrozole regimen had a superior efficacy as compared with clomiphene citrate in patients of unexplained infertility undergoing superovulation and IUI.

Trial registration: ClinicalTrials.gov, NCT01232075.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram of the study.
See this image and copyright information in PMC

References

    1. Evers JL. Female subfertility. Lancet. 2002;360(9327):151–159. doi: 10.1016/S0140-6736(02)09417-5. - DOI - PubMed
    1. Collins JA, Crosignani PG. Unexplained infertility: a review of, prognosis, treatment efficacy and management. Int J Gynecol Obstet. 1992;39(4):267–275. doi: 10.1016/0020-7292(92)90257-J. - DOI - PubMed
    1. Costello MF. Systematic review of the treatment of ovulatory infertility with clomiphene citrate and intrauterine insemination. Aust N Z J Obstet Gynaecol. 2004;44(2):93–102. doi: 10.1111/j.1479-828X.2004.00192.x. - DOI - PubMed
    1. Guzick DS, Sullivan MW, Adamson GD, Cedars MI, Falk RJ, Peterson EP, Steinkampf MP. Efficacy of treatment for unexplained infertility. Fertil Steril. 1998;70(2):207–213. doi: 10.1016/S0015-0282(98)00177-0. - DOI - PubMed
    1. Dickey RP, Holtkamp DE. Development, pharmacology and clinical experience with clomiphene citrate. Hum Reprod Update. 1996;2(6):483–506. doi: 10.1093/humupd/2.6.483. - DOI - PubMed

Publication types

Associated data